Patents by Inventor Hardev S. Pandha

Hardev S. Pandha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MELANOMA SPECIFIC BIOMARKER
    Publication number: 20120263654
    Abstract: Described are melanoma specific biomarkers comprising the nucleic acid sequence of the Engrailed-2 (EN2) gene or the amino acid sequence of the encoded EN2 protein. Also described are uses of the biomarkers in the treatment, diagnosis, monitoring and imaging of melanoma.
    Type: Application
    Filed: July 13, 2010
    Publication date: October 18, 2012
    Inventors: Richard Morgan, Hardev S. Pandha
  • BIOMARKER EN2 FOR GYNAECOLOGICAL CANCER
    Publication number: 20120219501
    Abstract: Described are gynaecological cancer specific biomarkers comprising the nucleic acid sequence of the Engrailed-2 (EN2) gene or the amino acid sequence of the encoded EN2 protein. Also described are uses of the biomarkers in the treatment, diagnosis, monitoring and imaging of gynaecological cancer.
    Type: Application
    Filed: July 13, 2010
    Publication date: August 30, 2012
    Inventors: Richard Morgan, Hardev S. Pandha
  • Biomarker
    Publication number: 20120183554
    Abstract: Described are gastrointestinal cancer specific biomarkers comprising the nucleic acid sequence of the Engrailed-2 (EN2) gene or the amino acid sequence of the encoded EN2 protein. Also described are uses of the biomarkers in the treatment, diagnosis, monitoring and imaging of gastrointestinal cancer.
    Type: Application
    Filed: July 13, 2010
    Publication date: July 19, 2012
    Inventors: Richard Morgan, Hardev S. Pandha
  • THERAPEUTIC PEPTIDES, POLYPEPTIDES AND NUCLEIC ACID SEQUENCES
    Publication number: 20120177672
    Abstract: Described are isolated peptides (GLGGGDLSV, SLNESQIKI, LMLPAVLQA and FTAEQLQRL) derived from portions of the Engrailed-2 (EN2) protein. Also described is their use in therapy, in particular in relation to the prevention and treatment of cancer.
    Type: Application
    Filed: July 13, 2010
    Publication date: July 12, 2012
    Applicant: The University of Surrey
    Inventors: Richard Morgan, Hardev S. Pandha
  • BIOMARKER
    Publication number: 20120020888
    Abstract: Described are bladder cancer specific biomarkers and lung cancer specific biomarkers comprising the nucleic acid sequence of the Engrailed-2 (EN2) gene or the amino acid sequence of the encoded EN2 protein. Also described are uses of the biomarkers in the treatment, diagnosis, monitoring and imaging of bladder cancer and lung cancer.
    Type: Application
    Filed: December 21, 2009
    Publication date: January 26, 2012
    Applicant: THE UNIVERSITY OF SURREY
    Inventors: Richard Morgan, Hardev S. Pandha